Literature DB >> 12874471

Blood pressure evaluation among older living kidney donors.

Stephen C Textor1, Sandra J Taler, Timothy S Larson, Mikel Prieto, Matthew Griffin, James Gloor, Scott Nyberg, Jorge Velosa, Thomas Schwab, Mark Stegall.   

Abstract

With more patients reaching end-stage renal disease, the demand for living kidney donation is increasing rapidly. Many potential donors are now in older age groups. The effects of increasing BP with age and the measurement criteria for hypertension in this group are not well defined. A total of 238 potential donors between 18 and 72 yr of age were prospectively studied, with a comparison of "clinic" BP values measured in the outpatient clinic with an oscillometric recorder (Dinamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by nurses using American Heart Association criteria. Renal function was evaluated on the basis of iothalamate clearance (GFR) and urinary protein and microalbumin excretion. Ninety-six percent of subjects were Caucasian. All subjects exhibited normal GFR and urinary protein excretion. Three age groups were defined (group I, </=35 yr, n = 64; group II, 36 to 49 yr, n = 109; group III, >/= 50 yr, n = 65). BP increased with age, as determined with all methods. Subjects >/= 50 yr of age exhibited the highest clinic readings (145 +/- 2/83 +/- 1 mmHg, compared with 129 +/- 2/76 +/- 1 mmHg for group I, P < 0.01). Awake ABPM and nurse-determined BP measurements were lower than clinic readings, including those for group III (131 +/- 2/80 +/- 1 mmHg, compared with 145 +/- 2/83 +/- 1 mmHg in the clinic, P < 0.001). With the use of systolic BP values of >140 mmHg and/or diastolic BP values of >90 mmHg, 36.7% of subjects were initially considered hypertensive; this proportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg). Measurement variability (SD in ABPM) and the effects of misclassification were greatest for donors >/= 50 yr of age. Multivariate regression indicated that GFR of both donors and recipients decreased with age, but regression identified no independent effect of BP. Recipient outcomes for up to 2 yr were equally good for donor kidneys considered normotensive or hypertensive on the basis of clinic BP measurements. These data indicate that higher arterial BP with age can lead to misclassification of many older living kidney donors. Sixty-two subjects with excellent kidney function were misclassified as hypertensive with clinic oscillometric measurements alone. Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874471     DOI: 10.1097/01.asn.0000077346.92039.9c

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Living donor kidney donation: another form of white coat effect.

Authors:  Stephanie S DeLoach; Kevin E C Meyers; Raymond R Townsend
Journal:  Am J Nephrol       Date:  2011-12-21       Impact factor: 3.754

2.  Diagnostic Performance of Blood Pressure Measurement Modalities in Living Kidney Donor Candidates.

Authors:  Sherif Armanyous; Yasushi Ohashi; Michael Lioudis; Jesse D Schold; George Thomas; Emilio D Poggio; Joshua J Augustine
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-04       Impact factor: 8.237

3.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

4.  Long-term renal function and cardiovascular disease risk in obese kidney donors.

Authors:  Mohammad M Tavakol; Flavio G Vincenti; Hamid Assadi; Michael J Frederick; Stephen J Tomlanovich; John P Roberts; Andrew M Posselt
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

5.  Risk assessment and management for medically complex potential living kidney donors: a few deontological criteria and ethical values.

Authors:  Carlo Petrini
Journal:  J Transplant       Date:  2011-12-07

6.  Renal function outcomes and kidney biopsy features of living kidney donors with hypertension.

Authors:  Massini A Merzkani; Aidan Mullan; Aleksandar Denic; Matthew D'Costa; Ryan Iverson; Walter Kremers; Mariam P Alexander; Stephen C Textor; Sandra J Taler; Mark D Stegall; Joshua Augustine; Naim Issa; Andrew D Rule
Journal:  Clin Transplant       Date:  2021-03-30       Impact factor: 3.456

7.  Utility of 24-hour ambulatory blood pressure monitoring in potential living kidney donors.

Authors:  Nabeel Aslam; Sobia H Memon; Hani Wadei; Elizabeth R Lesser; Shehzad K Niazi
Journal:  Clin Hypertens       Date:  2021-07-01

Review 8.  Controversies related to living kidney donors.

Authors:  Ahmed I Kamal; Ahmed M Harraz; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2011-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.